[{"id":10542,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/abcely\/","name":"abcely","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/02\/Logos-entreprise-site-web-BIO-2024-1.png","alt":""},"title":"3BIOTECH","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"F\u00e9v 16, 2024","dateGMT":"2024-02-16 18:32:28","modifiedDate":"2024-05-22 17:15:42","modifiedDateGMT":"2024-05-22 15:15:42","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/endometriosis\/' rel='post_tag'>Endometriosis<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immotherapy\/' rel='post_tag'>Immotherapy<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/inflammation\/' rel='post_tag'>Inflammation<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":7},"status":"publish","excerpt":"3Biotech provides continuously innovative solutions to challenge, support and accelerate the manufacturing of safe drug candidates."},{"id":11758,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/4p-pharma\/","name":"4p-pharma","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-64.png","alt":""},"title":"4P-PHARMA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 21:32:46","modifiedDate":"2024-04-26 17:31:34","modifiedDateGMT":"2024-04-26 15:31:34","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/chronic-and-autoimmune-diseases\/' rel='post_tag'>Chronic and autoimmune diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/ophtalmological-diseases\/' rel='post_tag'>ophtalmological diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/preventive-therapies\/' rel='post_tag'>preventive therapies<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/respiratory-and-infectious-diseases\/' rel='post_tag'>respiratory and infectious diseases<\/a>"},"readTime":{"min":1,"sec":7},"status":"publish","excerpt":"4P-Pharma is a clinical stage company dedicated to regenerate active drugs to develop first-in-class therapies to cure untreated serious diseases."},{"id":11033,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/abcely-2\/","name":"abcely-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-2024-05-22T114808.536.png","alt":""},"title":"ABCELY","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 9, 2024","dateGMT":"2024-04-09 17:48:40","modifiedDate":"2024-05-22 17:48:27","modifiedDateGMT":"2024-05-22 15:48:27","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/endometriosis\/' rel='post_tag'>Endometriosis<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immotherapy\/' rel='post_tag'>Immotherapy<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/inflammation\/' rel='post_tag'>Inflammation<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":23},"status":"publish","excerpt":"ABCELY is specialized in developping solutions for mucosal cancers and pioneering the development of a completely new class of therapeutic molecules."},{"id":11522,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/acticor-biotech\/","name":"acticor-biotech","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-38.png","alt":""},"title":"ACTICOR BIOTECH","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 14:10:41","modifiedDate":"2024-04-26 17:50:35","modifiedDateGMT":"2024-04-26 15:50:35","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/acute-ischemic-stroke\/' rel='post_tag'>Acute ischemic stroke<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cardiovascular-emergencies\/' rel='post_tag'>Cardiovascular emergencies<\/a>"},"readTime":{"min":1,"sec":2},"status":"publish","excerpt":"Acticor Biotech is a clinical stage biopharmaceutical company aiming to develop an innovative treatment for cardiovascular emergencies, including ischemic stroke."},{"id":11496,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/affilogic\/","name":"affilogic","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-35.png","alt":""},"title":"AFFILOGIC","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 13:54:10","modifiedDate":"2024-04-29 22:18:39","modifiedDateGMT":"2024-04-29 20:18:39","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cns-disorders\/' rel='post_tag'>CNS disorders<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectiology\/' rel='post_tag'>Infectiology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/inflammatory-diseases\/' rel='post_tag'>Inflammatory diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":0,"sec":39},"status":"publish","excerpt":"Affilogic is a private, French biotech company established in 2010. They are specialized in discovering and developing Nanofitins\u00ae."},{"id":11599,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/algenscribe\/","name":"algenscribe","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-47.png","alt":""},"title":"ALGENSCRIBE","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 15:27:17","modifiedDate":"2024-04-29 18:35:10","modifiedDateGMT":"2024-04-29 16:35:10","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/gene-editing\/' rel='post_tag'>Gene Editing<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/gene-therapy\/' rel='post_tag'>Gene Therapy<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":0,"sec":30},"status":"publish","excerpt":"Algenscribe is developing a new platform for Gene Replacement with its first applications in Gene Therapy and Oncology."},{"id":11417,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/altevax-biotech\/","name":"altevax-biotech","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-27.png","alt":""},"title":"ALTEVAX BIOTECH","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 16, 2024","dateGMT":"2024-04-16 20:31:11","modifiedDate":"2024-05-16 17:47:54","modifiedDateGMT":"2024-05-16 15:47:54","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/adjuvant-platform\/' rel='post_tag'>Adjuvant Platform<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/glioblastoma\/' rel='post_tag'>Glioblastoma<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immuno-oncology\/' rel='post_tag'>Immuno-Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immunotherapy\/' rel='post_tag'>Immunotherapy<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/therapeutic-vaccine\/' rel='post_tag'>Therapeutic Vaccine<\/a>"},"readTime":{"min":1,"sec":25},"status":"publish","excerpt":"ALTEVAX mastered the production process for synthetic melanin and its combination with peptides."},{"id":11386,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/alzprotect\/","name":"alzprotect","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-24.png","alt":""},"title":"ALZPROTECT","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 20:52:11","modifiedDate":"2024-04-26 17:56:51","modifiedDateGMT":"2024-04-26 15:56:51","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/alzheimers-disease\/' rel='post_tag'>Alzheimer's disease<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurodegenerative-diseases\/' rel='post_tag'>Neurodegenerative diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/parkinsons-disease\/' rel='post_tag'>Parkinson's disease<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/progressive-nuclear-palsy\/' rel='post_tag'>Progressive Nuclear Palsy<\/a>"},"readTime":{"min":0,"sec":59},"status":"publish","excerpt":"Alzprotect France focuses on creating therapies to slow or halt neurodegenerative diseases and rejuvenate brain function."},{"id":12054,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/amkbiotech\/","name":"amkbiotech","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-84-1.png","alt":""},"title":"AMKBIOTECH","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 18:01:10","modifiedDate":"2024-04-29 18:35:40","modifiedDateGMT":"2024-04-29 16:35:40","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/digitalhealth\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/digitalhealth\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/dermatology\/' rel='post_tag'>Dermatology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/histopathology\/' rel='post_tag'>Histopathology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/inflammatory-disease\/' rel='post_tag'>Inflammatory disease<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":0,"sec":29},"status":"publish","excerpt":"AMKbiotech is an innovative service laboratory proving highplex tissue imaging solutions for biomarker identification and target efficacy validation."},{"id":11668,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/antabio\/","name":"antabio","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-54-1.png","alt":""},"title":"ANTABIO","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 16:18:32","modifiedDate":"2024-04-29 18:37:35","modifiedDateGMT":"2024-04-29 16:37:35","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/bacterial-infection\/' rel='post_tag'>Bacterial infection<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/bacterial-pneumonia\/' rel='post_tag'>Bacterial Pneumonia<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/bronchiectasis\/' rel='post_tag'>Bronchiectasis<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cystic-fibrosis\/' rel='post_tag'>Cystic Fibrosis<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/gram-negative-bacterium-infection\/' rel='post_tag'>Gram negative bacterium infection<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectious-diseases\/' rel='post_tag'>Infectious diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/lung-infection\/' rel='post_tag'>Lung infection<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/multidrug-resistant-infection\/' rel='post_tag'>Multidrug resistant infection<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/urinary-tract-infection-respiratory-tract-infection\/' rel='post_tag'>Urinary Tract Infection; Respiratory Tract Infection<\/a>"},"readTime":{"min":1,"sec":11},"status":"publish","excerpt":"Antabio is a privately-held clinical stage biopharmaceutical company developing antibacterial treatments of drug-resistant infections due to WHO critical priority pathogens."},{"id":11954,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/aponia-therapeutics\/","name":"aponia-therapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-75.png","alt":""},"title":"APMONIA THERAPEUTICS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 15:31:48","modifiedDate":"2024-05-13 15:25:24","modifiedDateGMT":"2024-05-13 13:25:24","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":36},"status":"publish","excerpt":"Apmonia Therapeutics is a biotechnology company dedicated to developing therapeutic strategies towards cancer."},{"id":11106,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/aqemia\/","name":"aqemia","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-1.png","alt":""},"title":"AQEMIA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 9, 2024","dateGMT":"2024-04-09 18:51:50","modifiedDate":"2024-05-13 15:39:12","modifiedDateGMT":"2024-05-13 13:39:12","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/central-nervous-system\/' rel='post_tag'>Central Nervous System<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immunology\/' rel='post_tag'>Immunology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/inflammation\/' rel='post_tag'>Inflammation<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/metabolism\/' rel='post_tag'>Metabolism<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":0,"sec":30},"status":"publish","excerpt":"AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline."},{"id":11342,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/atlantic-bone-screen\/","name":"atlantic-bone-screen","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-18.png","alt":""},"title":"ATLANTIC BONE SCREEN","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 19:53:04","modifiedDate":"2024-05-13 15:35:43","modifiedDateGMT":"2024-05-13 13:35:43","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/biomaterials\/' rel='post_tag'>Biomaterials<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/bone-diseases\/' rel='post_tag'>Bone Diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cosmetics\/' rel='post_tag'>Cosmetics<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/dermatology\/' rel='post_tag'>Dermatology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/inflammation\/' rel='post_tag'>Inflammation<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/osteoarticular-diseases\/' rel='post_tag'>Osteoarticular Diseases<\/a>"},"readTime":{"min":1,"sec":7},"status":"publish","excerpt":"Atlantic Bone Screen is a French CRO providing non-GLP preclinical services specialized in he field of osteoarticular indications \/ bone and joint diseases \/ biomaterials"},{"id":11541,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/aurobac-therapeutics\/","name":"aurobac-therapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-40.png","alt":""},"title":"AUROBAC THERAPEUTICS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 14:26:04","modifiedDate":"2024-04-26 17:49:14","modifiedDateGMT":"2024-04-26 15:49:14","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/acute-respiratory-infections\/' rel='post_tag'>Acute Respiratory Infections<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/amr\/' rel='post_tag'>AMR<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/bacterial-infections\/' rel='post_tag'>Bacterial Infections<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/sepsis-septic-shock\/' rel='post_tag'>Sepsis & Septic Shock<\/a>"},"readTime":{"min":1,"sec":9},"status":"publish","excerpt":"AUROBAC THERAPEUTICS is a biopharmaceutical company aiming to develop the next generation of precision medicines and become leaders in the fight against bacterial infections, antimicrobial resistance, and their consequences."},{"id":11308,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/averoa\/","name":"averoa","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-13.png","alt":""},"title":"AVEROA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 19:22:51","modifiedDate":"2024-05-16 17:51:18","modifiedDateGMT":"2024-05-16 15:51:18","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/nephrology-and-metabolism\/' rel='post_tag'>Nephrology and Metabolism<\/a>"},"readTime":{"min":0,"sec":34},"status":"publish","excerpt":"AVEROA is an emerging company with a smart business focused on the development and registration of innovative drugs."},{"id":12146,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/bioaster\/","name":"bioaster","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-94.png","alt":""},"title":"BIOASTER","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 19:10:28","modifiedDate":"2024-05-13 15:21:01","modifiedDateGMT":"2024-05-13 13:21:01","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/antimicrobial\/' rel='post_tag'>Antimicrobial<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/antiviral\/' rel='post_tag'>Antiviral<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/auto-immune-diseases\/' rel='post_tag'>Auto-immune diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immuno-modulation\/' rel='post_tag'>Immuno-modulation<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immunology\/' rel='post_tag'>Immunology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectious-therapeutic-vaccines\/' rel='post_tag'>Infectious & therapeutic vaccines<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/inflammatory-diseases\/' rel='post_tag'>Inflammatory diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/ivd\/' rel='post_tag'>Ivd<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/microbiota\/' rel='post_tag'>Microbiota<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/support-to-bioprocess-optimization-bioproduction\/' rel='post_tag'>Support to bioprocess optimization & bioproduction<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/support-to-cmc\/' rel='post_tag'>Support to cmc<\/a>"},"readTime":{"min":1,"sec":7},"status":"publish","excerpt":"BIOASTER is the first Institute for Technological Innovation in Microbiology in France (Lyon and Paris, Pasteur Institute)."},{"id":11377,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/biophta\/","name":"biophta","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-23.png","alt":""},"title":"BIOPHTA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 20:43:29","modifiedDate":"2024-05-13 15:34:55","modifiedDateGMT":"2024-05-13 13:34:55","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/diabetic-macular-edema\/' rel='post_tag'>Diabetic macular edema<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/glaucoma\/' rel='post_tag'>Glaucoma<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/ophthalmology\/' rel='post_tag'>Ophthalmology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/retina\/' rel='post_tag'>Retina<\/a>"},"readTime":{"min":1,"sec":4},"status":"publish","excerpt":"BIOPHTA is a French (FDA pre-IND transforming ophthalmology to relieve patients in the treatment of their eye diseases."},{"id":13076,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/blends\/","name":"blends","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/05\/Logos-site-BIO-2024-Entreprises-2024-05-24T120658.724.png","alt":""},"title":"BLENDS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Mai 24, 2024","dateGMT":"2024-05-24 16:04:17","modifiedDate":"2024-05-24 18:08:03","modifiedDateGMT":"2024-05-24 16:08:03","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/other\/\" rel=\"category tag\">Institutions, Service Providers & others<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/other\/\" rel=\"category tag\">Institutions, Service Providers & others<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/all-therapeutic-areas\/' rel='post_tag'>All therapeutic areas<\/a>"},"readTime":{"min":0,"sec":54},"status":"publish","excerpt":"Blends provides research intelligence for biotech companies and labs. They deliver state-of-the-art systematic reviews within 24 hours."},{"id":11745,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/brenus-pharma\/","name":"brenus-pharma","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-63.png","alt":""},"title":"BRENUS PHARMA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 21:26:03","modifiedDate":"2024-05-06 21:08:44","modifiedDateGMT":"2024-05-06 19:08:44","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/liver-cancer\/' rel='post_tag'>Liver cancer<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/metastatic-colo-rectal-cancer\/' rel='post_tag'>Metastatic Colo Rectal Cancer<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/ovarian-cancer\/' rel='post_tag'>Ovarian Cancer<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/pancreas-cancer\/' rel='post_tag'>Pancreas Cancer<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/solid-tumors\/' rel='post_tag'>Solid Tumors<\/a>"},"readTime":{"min":1,"sec":29},"status":"publish","excerpt":"Brenus Pharma is a French clinical-stage biotech developing a pioneering discovery platform Stimulated-Tumor-Cell (STC) leading the path of a new generation of immunotherapies."},{"id":11608,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/cevidra\/","name":"cevidra","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-48.png","alt":""},"title":"CEVIDRA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 15:31:03","modifiedDate":"2024-04-29 18:38:03","modifiedDateGMT":"2024-04-29 16:38:03","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/addictive-medicine\/' rel='post_tag'>Addictive medicine<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/rare-diseases\/' rel='post_tag'>Rare diseases<\/a>"},"readTime":{"min":1,"sec":2},"status":"publish","excerpt":"CEVIDRA is an independent pharmaceutical company which acts as a gateway to the French market for foreign companies."},{"id":11475,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/chelatec\/","name":"chelatec","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-33.png","alt":""},"title":"CHELATEC","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 13:39:08","modifiedDate":"2024-04-29 21:43:32","modifiedDateGMT":"2024-04-29 19:43:32","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/targeted-therapy\/' rel='post_tag'>Targeted therapy<\/a>"},"readTime":{"min":0,"sec":31},"status":"publish","excerpt":"Chelatec is recognized for its reliable expertise and offers a unique combination of custom radiolabeling, in vitro assays and in vivo investigations capabilities."},{"id":12031,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/cilcare\/","name":"cilcare","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-82.png","alt":""},"title":"CILCARE","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 17:14:37","modifiedDate":"2024-04-29 18:38:51","modifiedDateGMT":"2024-04-29 16:38:51","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/auditory-health-and-associated-neuro-inflammatory-diseases\/' rel='post_tag'>Auditory health and associated neuro-inflammatory diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cochlear-synaptopathy\/' rel='post_tag'>Cochlear Synaptopathy<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/deafness\/' rel='post_tag'>Deafness<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/hearing-disorders\/' rel='post_tag'>Hearing disorders<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/otology\/' rel='post_tag'>Otology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/tinnitus\/' rel='post_tag'>Tinnitus<\/a>"},"readTime":{"min":1,"sec":24},"status":"publish","excerpt":"Developing its own assets coupled with a unique AI-driven approach, Cilcare focuses on cochlear synaptopathy treatment and associated neuro-inflammatory disorders."},{"id":11427,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/crossject\/","name":"crossject","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-28.png","alt":""},"title":"CROSSJECT","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 16, 2024","dateGMT":"2024-04-16 20:36:50","modifiedDate":"2024-04-26 17:55:31","modifiedDateGMT":"2024-04-26 15:55:31","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/allergy\/' rel='post_tag'>Allergy<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/asthma\/' rel='post_tag'>Asthma<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/endocrinology\/' rel='post_tag'>Endocrinology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/epilepsy\/' rel='post_tag'>Epilepsy<\/a>"},"readTime":{"min":1,"sec":6},"status":"publish","excerpt":"Crossject SA is an emerging specialty pharma company, in advanced regulatory development for ZEPIZURE\u00ae, an epileptic rescue therapy."},{"id":11457,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/cynbiose\/","name":"cynbiose","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-31.png","alt":""},"title":"CYNBIOSE","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 16, 2024","dateGMT":"2024-04-16 21:10:30","modifiedDate":"2024-05-22 21:31:42","modifiedDateGMT":"2024-05-22 19:31:42","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/central-nervous-system-cns\/' rel='post_tag'>Central nervous system (CNS)<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immune-disorders-inflammation\/' rel='post_tag'>Immune disorders & inflammation<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectious-diseases\/' rel='post_tag'>Infectious diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/respiratory-diseases\/' rel='post_tag'>Respiratory diseases<\/a>"},"readTime":{"min":1,"sec":13},"status":"publish","excerpt":"Cynbiose is a preclinical CRO specialized in non-human primate (NHP) translational models for biomedical research since 2008."},{"id":11293,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/eg427\/","name":"eg427","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-11.png","alt":""},"title":"EG427","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 19:07:00","modifiedDate":"2024-04-26 18:13:20","modifiedDateGMT":"2024-04-26 16:13:20","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neuro-urology\/' rel='post_tag'>Neuro-urology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurology\/' rel='post_tag'>Neurology<\/a>"},"readTime":{"min":1,"sec":5},"status":"publish","excerpt":"Based on their unique vector platform, EG427 delivers pinpoint neurotherapeutics to treat prevalent diseases of the peripheral and central nervous system."},{"id":11117,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/exeliom-biosciences\/","name":"exeliom-biosciences","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-2.png","alt":""},"title":"EXELIOM BIOSCIENCES","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 9, 2024","dateGMT":"2024-04-09 19:00:37","modifiedDate":"2024-04-26 18:21:38","modifiedDateGMT":"2024-04-26 16:21:38","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immuno-oncology\/' rel='post_tag'>Immuno-Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectious-disease\/' rel='post_tag'>Infectious Disease<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/inflammatory-bowel-disease\/' rel='post_tag'>Inflammatory Bowel Disease<\/a>"},"readTime":{"min":1,"sec":25},"status":"publish","excerpt":"Exeliom Biosciences is developing a new generation of immunotherapies based on therapeutic targets that play a critical role in our innate immunity."},{"id":11485,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/fabentech\/","name":"fabentech","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-34.png","alt":""},"title":"FABENTECH","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 13:43:00","modifiedDate":"2024-05-16 17:50:21","modifiedDateGMT":"2024-05-16 15:50:21","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/biodefense\/' rel='post_tag'>Biodefense<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectious-diseases\/' rel='post_tag'>Infectious diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/intoxications\/' rel='post_tag'>Intoxications<\/a>"},"readTime":{"min":1,"sec":14},"status":"publish","excerpt":"Fabentech is a leading biopharmaceutical company specializing in the development and production of emergency treatments to combat the most critical biological threats to public health."},{"id":11559,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/firalis-molecular-precision\/","name":"firalis-molecular-precision","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-42.png","alt":""},"title":"FIRALIS MOLECULAR PRECISION","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 15:00:44","modifiedDate":"2024-05-13 15:33:14","modifiedDateGMT":"2024-05-13 13:33:14","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immunology\/' rel='post_tag'>Immunology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurology\/' rel='post_tag'>Neurology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":0,"sec":55},"status":"publish","excerpt":"Firalis Molecular Precision accelerates precision medicine by improving diagnostics, understanding disease mechanisms, and evaluating drug efficacy."},{"id":11223,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/h-a-c-pharma\/","name":"h-a-c-pharma","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-8.png","alt":""},"title":"H.A.C PHARMA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 10, 2024","dateGMT":"2024-04-10 16:25:34","modifiedDate":"2024-04-26 18:16:44","modifiedDateGMT":"2024-04-26 16:16:44","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/autoimmune-diseases\/' rel='post_tag'>Autoimmune diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cardiology\/' rel='post_tag'>Cardiology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cns\/' rel='post_tag'>CNS<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/endocrinology\/' rel='post_tag'>Endocrinology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/gynecology\/' rel='post_tag'>Gynecology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/hemato-oncology\/' rel='post_tag'>Hemato-oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurology\/' rel='post_tag'>Neurology<\/a>"},"readTime":{"min":0,"sec":46},"status":"publish","excerpt":"H.A.C. Pharma is a European pharmaceutical company incorporated in 2007 in France. H.A.C."},{"id":11551,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/hermerion-therapeutics\/","name":"hermerion-therapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-41.png","alt":""},"title":"HERMERION THERAPEUTICS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 14:53:08","modifiedDate":"2024-04-26 17:47:42","modifiedDateGMT":"2024-04-26 15:47:42","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/brain-tumor\/' rel='post_tag'>Brain Tumor<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neuro-oncology\/' rel='post_tag'>Neuro-Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurosurgery\/' rel='post_tag'>Neurosurgery<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":47},"status":"publish","excerpt":"Hermerion are developing a first-line treatment for newly diagnosed Glioblastoma (GBM) that integrates with surgery before the administration of adjuvant therapies."},{"id":11364,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/horiana\/","name":"horiana","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-22.png","alt":""},"title":"HORIANA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 20:29:13","modifiedDate":"2024-04-26 18:47:57","modifiedDateGMT":"2024-04-26 16:47:57","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/other\/\" rel=\"category tag\">Institutions, Service Providers & others<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/other\/\" rel=\"category tag\">Institutions, Service Providers & others<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cardiology\/' rel='post_tag'>Cardiology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/hematology\/' rel='post_tag'>Hematology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immunology\/' rel='post_tag'>Immunology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectious-diseases\/' rel='post_tag'>Infectious diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurology\/' rel='post_tag'>Neurology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/onocology\/' rel='post_tag'>Onocology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/rare-disease\/' rel='post_tag'>Rare disease<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/vaccines\/' rel='post_tag'>Vaccines<\/a>"},"readTime":{"min":1,"sec":3},"status":"publish","excerpt":"HORIANA is a premier consulting company dedicated to epidemiology and biostatistics, specializing in designing and conducting Healthcare Real-World Studies."},{"id":11437,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/htl-biotechnology\/","name":"htl-biotechnology","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-29.png","alt":""},"title":"HTL BIOTECHNOLOGY","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 16, 2024","dateGMT":"2024-04-16 20:51:03","modifiedDate":"2024-04-16 22:57:04","modifiedDateGMT":"2024-04-16 20:57:04","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/dermatology\/' rel='post_tag'>Dermatology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/medical-aesthetics\/' rel='post_tag'>Medical aesthetics<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/ophtalmology\/' rel='post_tag'>Ophtalmology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/rheumatology\/' rel='post_tag'>Rheumatology<\/a>"},"readTime":{"min":1,"sec":28},"status":"publish","excerpt":"HTL Biotechnology is a world leader in the development and responsible bioproduction of pharmaceutical-grade biopolymers."},{"id":11167,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/iktos\/","name":"iktos","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-6.png","alt":""},"title":"IKTOS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 9, 2024","dateGMT":"2024-04-09 19:40:15","modifiedDate":"2024-05-13 15:37:00","modifiedDateGMT":"2024-05-13 13:37:00","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/digitalhealth\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/digitalhealth\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cns\/' rel='post_tag'>CNS<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immunology\/' rel='post_tag'>Immunology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectious-diseases\/' rel='post_tag'>Infectious diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurology\/' rel='post_tag'>Neurology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/onconcology\/' rel='post_tag'>Onconcology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/rare-diseases\/' rel='post_tag'>Rare diseases<\/a>"},"readTime":{"min":1,"sec":37},"status":"publish","excerpt":"Iktos is a French start-up company specialized in the development of artificial intelligence solutions applied to chemical research."},{"id":11779,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/inflectis-bioscience\/","name":"inflectis-bioscience","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-66.png","alt":""},"title":"INFLECTIS BIOSCIENCE","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 19, 2024","dateGMT":"2024-04-19 17:46:30","modifiedDate":"2024-04-29 21:44:05","modifiedDateGMT":"2024-04-29 19:44:05","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurology\/' rel='post_tag'>Neurology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/rare-diseases\/' rel='post_tag'>Rare diseases<\/a>"},"readTime":{"min":0,"sec":53},"status":"publish","excerpt":"InFlectis is a French-based drug discovery company developing first-in-class therapies for neurological rare diseases."},{"id":11235,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/karla-therapeutics\/","name":"karla-therapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/DvJgYkW7SGPZoobGYGMUeZVWBd6eA3deLCaAeLoe1WM.jpg","alt":""},"title":"KARLA THERAPEUTICS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 10, 2024","dateGMT":"2024-04-10 17:36:29","modifiedDate":"2024-04-29 21:25:50","modifiedDateGMT":"2024-04-29 19:25:50","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cns\/' rel='post_tag'>CNS<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neuropsychiatry\/' rel='post_tag'>Neuropsychiatry<\/a>"},"readTime":{"min":0,"sec":49},"status":"publish","excerpt":"Karla is the first immuno-psychiatry company developing precision therapeutics to treat mental disorders"},{"id":11533,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/lys-therapeutics\/","name":"lys-therapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-39.png","alt":""},"title":"LYS THERAPEUTICS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 14:19:58","modifiedDate":"2024-04-29 21:03:10","modifiedDateGMT":"2024-04-29 19:03:10","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cns\/' rel='post_tag'>CNS<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurodegenerative-disorders\/' rel='post_tag'>Neurodegenerative disorders<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurology\/' rel='post_tag'>Neurology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurovascular-diseases\/' rel='post_tag'>Neurovascular diseases<\/a>"},"readTime":{"min":1,"sec":12},"status":"publish","excerpt":"Lys Therapeutics is a pioneering biotechnology company dedicated to addressing unmet medical needs in patients afflicted with neurovascular or neurodegenerative disorders."},{"id":12056,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/maat-pharma\/","name":"maat-pharma","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-85.png","alt":""},"title":"MAAT PHARMA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 18:04:27","modifiedDate":"2024-04-30 17:24:21","modifiedDateGMT":"2024-04-30 15:24:21","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/hemato-oncology\/' rel='post_tag'>Hemato-oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurodegenerative-diseases\/' rel='post_tag'>Neurodegenerative diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":10},"status":"publish","excerpt":"MaaT Pharma is the leading microbiome company in oncology specialized in developing Microbiome Ecosystem Therapies dedicated to enhancing the survival of cancer patients."},{"id":11799,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/mabqi\/","name":"mabqi","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-69.png","alt":""},"title":"MABQI","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 19, 2024","dateGMT":"2024-04-19 18:32:13","modifiedDate":"2024-04-30 17:27:03","modifiedDateGMT":"2024-04-30 15:27:03","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immune-diseases\/' rel='post_tag'>Immune diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":0,"sec":59},"status":"publish","excerpt":"Mabqi is a high-tech developer developping core technology platform which allows the development of functional antibodies with high developability through proprietary synthetic human libraries."},{"id":11771,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/mabsilico\/","name":"mabsilico","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-65.png","alt":""},"title":"MABSILICO","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 21:41:07","modifiedDate":"2024-04-18 23:44:38","modifiedDateGMT":"2024-04-18 21:44:38","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/computational-antibody-design-discovery-applied-in-oncology\/' rel='post_tag'>Computational antibody design & discovery applied in oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immuno-oncology\/' rel='post_tag'>Immuno-Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectious-diseases\/' rel='post_tag'>Infectious diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/rare-diseases\/' rel='post_tag'>Rare diseases<\/a>"},"readTime":{"min":1,"sec":6},"status":"publish","excerpt":"MAbSilico is the TechBio pionner company specializing in computational solutions for discovering and designing therapeutic antibodies."},{"id":11396,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/netris-pharma\/","name":"netris-pharma","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-25.png","alt":""},"title":"NETRIS PHARMA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 16, 2024","dateGMT":"2024-04-16 20:14:20","modifiedDate":"2024-04-30 17:32:55","modifiedDateGMT":"2024-04-30 15:32:55","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/women-health\/' rel='post_tag'>Women Health<\/a>"},"readTime":{"min":0,"sec":25},"status":"publish","excerpt":"Netris Pharma is a clinical-stage company developing innovative therapeutics to improve treatment outcome for cancer patients."},{"id":11987,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/neuron-experts\/","name":"neuron-experts","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-78.png","alt":""},"title":"NEURON EXPERTS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 15:54:40","modifiedDate":"2024-04-29 18:40:58","modifiedDateGMT":"2024-04-29 16:40:58","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neurodegenerative-disease\/' rel='post_tag'>Neurodegenerative disease<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/skin-disease\/' rel='post_tag'>Skin disease<\/a>"},"readTime":{"min":0,"sec":34},"status":"publish","excerpt":"Neuron Experts is a private CRO, createdin 2008, specialized in cultures of neurons mimicking neurodegenerative diseases."},{"id":11281,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/karla-therapeutics-2\/","name":"karla-therapeutics-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-10.png","alt":""},"title":"NG BIOTECH","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 18:47:53","modifiedDate":"2024-04-29 22:22:12","modifiedDateGMT":"2024-04-29 20:22:12","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/antimicrobial-resistance\/' rel='post_tag'>Antimicrobial Resistance<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectious-disease\/' rel='post_tag'>Infectious Disease<\/a>"},"readTime":{"min":0,"sec":42},"status":"publish","excerpt":"NG BIOTECH make rapid diagnostics that improve healthcare outcomes within antimicrobial resistance, infectious disease, liver function, and women's health."},{"id":11965,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/nicox\/","name":"nicox","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-76.png","alt":""},"title":"NICOX","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 15:43:35","modifiedDate":"2024-04-29 18:41:41","modifiedDateGMT":"2024-04-29 16:41:41","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/ophtalmology\/' rel='post_tag'>Ophtalmology<\/a>"},"readTime":{"min":1,"sec":11},"status":"publish","excerpt":"Nicox is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health."},{"id":13061,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/okomera-2\/","name":"okomera-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/05\/Logos-site-BIO-2024-Entreprises-2024-05-21T130958.116.png","alt":""},"title":"OKOMERA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Mai 22, 2024","dateGMT":"2024-05-22 15:44:21","modifiedDate":"2024-05-22 20:00:57","modifiedDateGMT":"2024-05-22 18:00:57","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cancer-therapies\/' rel='post_tag'>Cancer therapies<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cell-therapy\/' rel='post_tag'>Cell therapy<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/chemotherapy\/' rel='post_tag'>Chemotherapy<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/combined-therapies\/' rel='post_tag'>Combined therapies<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":0,"sec":40},"status":"publish","excerpt":"Okomera specializes in automated 3D organoid screening technology that accelerates access to improved, precision-based cancer therapies."},{"id":11092,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/oncodesign\/","name":"oncodesign","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises.png","alt":""},"title":"ONCODESIGN","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 9, 2024","dateGMT":"2024-04-09 18:44:05","modifiedDate":"2024-04-30 17:42:17","modifiedDateGMT":"2024-04-30 15:42:17","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":11},"status":"publish","excerpt":"OPM's mission is to provide patients with effective therapeutic and diagnostic solutions for resistant and metastatic cancers."},{"id":11793,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/orakl-oncology\/","name":"orakl-oncology","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-68.png","alt":""},"title":"ORAKL ONCOLOGY","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 19, 2024","dateGMT":"2024-04-19 18:21:37","modifiedDate":"2024-04-30 17:46:25","modifiedDateGMT":"2024-04-30 15:46:25","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/digitalhealth\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/digitalhealth\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":37},"status":"publish","excerpt":"Orakl Oncology stands at the forefront of the techbio landscape, pioneering the use of patient tumor avatars."},{"id":12007,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/ose-immunotherapeutics\/","name":"ose-immunotherapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-80.png","alt":""},"title":"OSE IMMUNOTHERAPEUTICS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 16:04:20","modifiedDate":"2024-04-30 17:24:47","modifiedDateGMT":"2024-04-30 15:24:47","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immuno-oncology-autoimmune-diseases\/' rel='post_tag'>Immuno-oncology; Autoimmune diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/inflammatory-diseases\/' rel='post_tag'>Inflammatory diseases<\/a>"},"readTime":{"min":0,"sec":42},"status":"publish","excerpt":"OSE Immunotherapeutics is an integrated Clinical Stage biotech company mastering complex biology with regards to T-cells and myeloid cells."},{"id":11311,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/owkin\/","name":"owkin","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-14.png","alt":""},"title":"OWKIN","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 19:28:57","modifiedDate":"2024-05-13 15:36:22","modifiedDateGMT":"2024-05-13 13:36:22","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cardiovascular\/' rel='post_tag'>Cardiovascular<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immunology-and-inflammation\/' rel='post_tag'>Immunology and Inflammation<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":13},"status":"publish","excerpt":"By understanding complex biology through artificial intelligence, Owkin integrates the best of human and AI capabilities to develop improved drugs and diagnostics at scale."},{"id":11334,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/pep-therapy\/","name":"pep-therapy","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-17.png","alt":""},"title":"PEP-THERAPY","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 19:48:01","modifiedDate":"2024-05-16 17:48:29","modifiedDateGMT":"2024-05-16 15:48:29","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cancer\/' rel='post_tag'>Cancer<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":6},"status":"publish","excerpt":"PEP-Therapy is a clinical-stage company developing first-in-class peptides as targeted therapies for the treatment of aggressive cancers."},{"id":11327,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/persea\/","name":"persea","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-16.png","alt":""},"title":"PERSEA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 19:43:27","modifiedDate":"2024-05-16 17:45:07","modifiedDateGMT":"2024-05-16 15:45:07","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/liver-cancers\/' rel='post_tag'>Liver cancers<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/solid-cancers\/' rel='post_tag'>Solid cancers<\/a>"},"readTime":{"min":1,"sec":2},"status":"publish","excerpt":"Persea is a French biotech developing a game-changing treatment against liver cancers: BioTrojan."},{"id":11735,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/phostin-therapeutics\/","name":"phostin-therapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-62.png","alt":""},"title":"PHOST'IN THERAPEUTICS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 21:21:46","modifiedDate":"2024-04-29 18:22:38","modifiedDateGMT":"2024-04-29 16:22:38","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/fibrosis\/' rel='post_tag'>Fibrosis<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":0,"sec":19},"status":"publish","excerpt":"Phost'in develops First-in-Class N-glycosylation inhibitors for the treatment of cancers and fibrosis (First-in-Human currently on-going in Europe for the first program)."},{"id":11975,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/pk-med\/","name":"pk-med","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-2024-05-22T112031.137.png","alt":""},"title":"PK MED","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 15:48:33","modifiedDate":"2024-05-22 17:21:56","modifiedDateGMT":"2024-05-22 15:21:56","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/bone-marrow-transplantation\/' rel='post_tag'>Bone marrow transplantation<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/rheumatology\/' rel='post_tag'>Rheumatology<\/a>"},"readTime":{"min":0,"sec":56},"status":"publish","excerpt":"PK MED specializes in the innovative development of custom-designed, injectable, and biodegradable micro-implants."},{"id":11714,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/product-life-group\/","name":"product-life-group","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-60.png","alt":""},"title":"PRODUCT LIFE GROUP","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 21:08:57","modifiedDate":"2024-04-26 17:33:57","modifiedDateGMT":"2024-04-26 15:33:57","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/all-therapeutic-areas\/' rel='post_tag'>All therapeutic areas<\/a>"},"readTime":{"min":0,"sec":56},"status":"publish","excerpt":"Product Life Group The team offers flexible consulting approach tailored to Biotechs regulatory needs and covering all therapeutic areas and drug modalities."},{"id":11648,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/qubit-pharmaceuticals\/","name":"qubit-pharmaceuticals","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-52.png","alt":""},"title":"QUBIT PHARMACEUTICALS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 16:06:12","modifiedDate":"2024-05-13 15:30:11","modifiedDateGMT":"2024-05-13 13:30:11","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cancer-resistance\/' rel='post_tag'>Cancer resistance<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/chronic-inflammatory-diseases\/' rel='post_tag'>Chronic inflammatory diseases<\/a>"},"readTime":{"min":1,"sec":27},"status":"publish","excerpt":"Qubit Pharmaceuticals specializes in \u2018in silico\u2019 drug discovery for challenging disease targets using small molecules by the pharmaceutical community."},{"id":11355,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/rd-biotech\/","name":"rd-biotech","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-20.png","alt":""},"title":"RD-BIOTECH","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 20:19:15","modifiedDate":"2024-04-29 21:28:34","modifiedDateGMT":"2024-04-29 19:28:34","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/other\/\" rel=\"category tag\">Institutions, Service Providers & others<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/other\/\" rel=\"category tag\">Institutions, Service Providers & others<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/car-t-cells\/' rel='post_tag'>CAR-T cells<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cell-and-gene-therapie\/' rel='post_tag'>Cell and Gene therapie<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/dna-vaccines\/' rel='post_tag'>DNA vaccines<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/rna-vaccines\/' rel='post_tag'>RNA vaccines<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/viral-based-therapies\/' rel='post_tag'>Viral Based Therapies<\/a>"},"readTime":{"min":0,"sec":56},"status":"publish","excerpt":"RD-Biotech is specialized in the supply of plasmid DNA, recombinant antibodies, and associated fragments, as well as monoclonal antibodies and recombinant proteins."},{"id":12099,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/rondol-industrie\/","name":"rondol-industrie","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-89.png","alt":""},"title":"RONDOL INDUSTRIE","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 18:29:16","modifiedDate":"2024-05-13 15:23:28","modifiedDateGMT":"2024-05-13 13:23:28","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/drug-formulation\/' rel='post_tag'>Drug Formulation<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/medical-device\/' rel='post_tag'>Medical Device<\/a>"},"readTime":{"min":1,"sec":10},"status":"publish","excerpt":"Rondol Industrie have been created in 2012 with the goal of adapting hot melt extrusion technology to the micro scale and to Pharma standards."},{"id":12551,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/roowin-sa\/","name":"roowin-sa","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/05\/Logos-site-BIO-2024-Entreprises-97.png","alt":""},"title":"ROOWIN SA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Mai 2, 2024","dateGMT":"2024-05-02 19:52:07","modifiedDate":"2024-05-13 15:20:06","modifiedDateGMT":"2024-05-13 13:20:06","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/other\/\" rel=\"category tag\">Institutions, Service Providers & others<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/other\/\" rel=\"category tag\">Institutions, Service Providers & others<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/all-therapeutic-areas\/' rel='post_tag'>All therapeutic areas<\/a>"},"readTime":{"min":0,"sec":47},"status":"publish","excerpt":"Roowin offers a large range of chemical services to support their customers and partners to advance their drug candidates from early research phase up to licensing out API in phase II or to the Market for small batches."},{"id":11350,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/rosetta-omics\/","name":"rosetta-omics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-19.png","alt":""},"title":"ROSETTA OMICS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 20:16:08","modifiedDate":"2024-05-16 17:45:51","modifiedDateGMT":"2024-05-16 15:45:51","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/ai\/' rel='post_tag'>AI<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cancer\/' rel='post_tag'>Cancer<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/colon-cancer\/' rel='post_tag'>Colon cancer<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/liver-cancers\/' rel='post_tag'>Liver cancers<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/precision-medicine\/' rel='post_tag'>Precision medicine<\/a>"},"readTime":{"min":0,"sec":58},"status":"publish","excerpt":"Rosetta Omics pioneers precision medicine through tumor characterization using spatial multiomics, deep mass spectrometry and AI."},{"id":12082,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/seqens\/","name":"seqens","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-87.png","alt":""},"title":"SEQENS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 18:18:01","modifiedDate":"2024-04-29 21:33:52","modifiedDateGMT":"2024-04-29 19:33:52","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":6},"status":"publish","excerpt":"SEQENS is a global partner in health, personal care and specialty ingredients."},{"id":11214,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/step-pharma-sas\/","name":"step-pharma-sas","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-7.png","alt":""},"title":"STEP PHARMA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 10, 2024","dateGMT":"2024-04-10 16:19:50","modifiedDate":"2024-04-26 18:17:30","modifiedDateGMT":"2024-04-26 16:17:30","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/haematology\/' rel='post_tag'>Haematology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":34},"status":"publish","excerpt":"Step Pharma is the world leader in the discovery and development of inhibitors of CTPS1 for the treatment of cancer and autoimmune diseases."},{"id":11300,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/stromacare\/","name":"stromacare","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-12.png","alt":""},"title":"STROMACARE","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 15, 2024","dateGMT":"2024-04-15 19:12:39","modifiedDate":"2024-04-30 17:37:42","modifiedDateGMT":"2024-04-30 15:37:42","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immune-diseases\/' rel='post_tag'>Immune diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":1,"sec":11},"status":"publish","excerpt":"StromaCare is a biotech company specialized in discovering and developing new cancer treatments through their understanding of stromal tissue biology."},{"id":11996,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/surge-care\/","name":"surge-care","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-79.png","alt":""},"title":"SURGE CARE","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 15:59:01","modifiedDate":"2024-05-13 15:24:44","modifiedDateGMT":"2024-05-13 13:24:44","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/immunology\/' rel='post_tag'>Immunology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/precision-medicine\/' rel='post_tag'>Precision medicine<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/surgery\/' rel='post_tag'>Surgery<\/a>"},"readTime":{"min":1,"sec":26},"status":"publish","excerpt":"Founded with the goal of revolutionizing precision medicine, Surge is an innovative company specializing in in-depth understanding of the immune system using AI."},{"id":12647,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/surgimab\/","name":"surgimab","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/05\/Logos-site-BIO-2024-Entreprises-98.png","alt":""},"title":"SURGIMAB","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Mai 7, 2024","dateGMT":"2024-05-07 13:06:27","modifiedDate":"2024-05-13 15:16:21","modifiedDateGMT":"2024-05-13 13:16:21","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/molecular-imaging\/' rel='post_tag'>Molecular Imaging<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/surgery\/' rel='post_tag'>Surgery<\/a>"},"readTime":{"min":1,"sec":21},"status":"publish","excerpt":"SurgiMab\u2019s tumor-targeting fluorescent molecules enable real time visualization of tumor margins and micro-tumors which are invisible to the naked eye."},{"id":11591,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/syncrosome\/","name":"syncrosome","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-46.png","alt":""},"title":"SYNCROSOME","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 15:22:57","modifiedDate":"2024-04-29 18:44:26","modifiedDateGMT":"2024-04-29 16:44:26","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/other\/\" rel=\"category tag\">Institutions, Service Providers & others<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/other\/\" rel=\"category tag\">Institutions, Service Providers & others<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cardiology\/' rel='post_tag'>Cardiology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cns\/' rel='post_tag'>CNS<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/dermatology\/' rel='post_tag'>Dermatology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/gastrology\/' rel='post_tag'>Gastrology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/respiratory-and-metabolic-disorders\/' rel='post_tag'>Respiratory and Metabolic disorders<\/a>"},"readTime":{"min":0,"sec":24},"status":"publish","excerpt":"SYNCROSOME is a CRO specialized in vivo efficacy studies with high expertise in cardiovascular, CNS, dermatology gastroenterology and metabolic disorders."},{"id":11568,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/banook-grp\/","name":"banook-grp","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-44.png","alt":""},"title":"SYNDIVIA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 15:09:15","modifiedDate":"2024-05-13 15:32:24","modifiedDateGMT":"2024-05-13 13:32:24","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/antibody-drug-conjgutes\/' rel='post_tag'>Antibody-drug-conjgutes<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":0,"sec":39},"status":"publish","excerpt":"Syndivia is dedicated to enhancing treatment options for patients with solid tumors. They specialize in utilizing their proprietary and unique GeminiMab\u2122 technology."},{"id":11725,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/temisis\/","name":"temisis","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-61.png","alt":""},"title":"TEMISIS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 21:15:54","modifiedDate":"2024-05-13 15:27:09","modifiedDateGMT":"2024-05-13 13:27:09","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/auto-immune-diseases\/' rel='post_tag'>Auto-immune diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/inflammatory-diseases\/' rel='post_tag'>Inflammatory diseases<\/a>"},"readTime":{"min":1,"sec":9},"status":"publish","excerpt":"Temisis is developing innovative therapeutics for patients living with chronic inflammatory and auto-immune diseases, with a primary focus on psoriasis."},{"id":11467,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/theranexus\/","name":"theranexus","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-32.png","alt":""},"title":"THERANEXUS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 16, 2024","dateGMT":"2024-04-16 21:16:33","modifiedDate":"2024-05-16 17:50:53","modifiedDateGMT":"2024-05-16 15:50:53","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cns\/' rel='post_tag'>CNS<\/a>"},"readTime":{"min":0,"sec":21},"status":"publish","excerpt":"Theranexus is a French biopharmaceutical company discovering and developing treatments to meet the needs of patients with rare neurological disorders."},{"id":11447,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/theravia-addmedica\/","name":"theravia-addmedica","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-30.png","alt":""},"title":"THERAVIA (ADDMEDICA)","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 16, 2024","dateGMT":"2024-04-16 20:58:42","modifiedDate":"2024-04-30 17:29:30","modifiedDateGMT":"2024-04-30 15:29:30","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neglected-disorders\/' rel='post_tag'>Neglected disorders<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/paediatric-diseases\/' rel='post_tag'>Paediatric diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/rare-diseases\/' rel='post_tag'>Rare diseases<\/a>"},"readTime":{"min":1,"sec":14},"status":"publish","excerpt":"THERAVIA is a European-based company dedicated to the development, marketing, and distribution of products dedicated to serious conditions."},{"id":11659,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/truffle-capital\/","name":"truffle-capital","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-53.png","alt":""},"title":"TRUFFLE CAPITAL","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 16:12:25","modifiedDate":"2024-04-26 17:40:20","modifiedDateGMT":"2024-04-26 15:40:20","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/infectious-diseases\/' rel='post_tag'>Infectious diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/joint-diseases\/' rel='post_tag'>joint diseases<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/rheumatalogy\/' rel='post_tag'>rheumatalogy<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/transplants\/' rel='post_tag'>Transplants<\/a>"},"readTime":{"min":0,"sec":15},"status":"publish","excerpt":"For 20 years, Truffle Capital has been financing innovations, growing and empowering technology leaders in healthcare & finance."},{"id":11923,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/vect-horus\/","name":"vect-horus","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-72.png","alt":""},"title":"VECT-HORUS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 22, 2024","dateGMT":"2024-04-22 15:15:43","modifiedDate":"2024-04-30 17:26:23","modifiedDateGMT":"2024-04-30 15:26:23","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cardiovascular\/' rel='post_tag'>Cardiovascular<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/central-nervous-system\/' rel='post_tag'>Central Nervous System<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/neuromuscular\/' rel='post_tag'>Neuromuscular<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/ophtalmological\/' rel='post_tag'>Ophtalmological<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/pulmonary\/' rel='post_tag'>Pulmonary<\/a>"},"readTime":{"min":1,"sec":20},"status":"publish","excerpt":"Vect-Horus is a privately held biotechnology company that designs and develops molecular vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs."},{"id":11506,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/whitelab-genomics\/","name":"whitelab-genomics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-36.png","alt":""},"title":"WHITELAB GENOMICS","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 14:00:28","modifiedDate":"2024-05-22 21:23:37","modifiedDateGMT":"2024-05-22 19:23:37","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/cell-and-gene-therapies\/' rel='post_tag'>Cell and Gene therapies<\/a>"},"readTime":{"min":0,"sec":43},"status":"publish","excerpt":"WhiteLab Genomics stands at the convergence of computer sciences and biology, pioneering the accelerated development of genomic medicines."},{"id":11583,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/xenothera\/","name":"xenothera","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-45.png","alt":""},"title":"XENOTHERA","author":{"name":"jberthold","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/jberthold\/"},"date":"Avr 18, 2024","dateGMT":"2024-04-18 15:18:34","modifiedDate":"2024-04-30 17:27:45","modifiedDateGMT":"2024-04-30 15:27:45","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/acute-graft-rejection\/' rel='post_tag'>Acute Graft rejection<\/a><a href='https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/tag\/oncology\/' rel='post_tag'>Oncology<\/a>"},"readTime":{"min":0,"sec":38},"status":"publish","excerpt":"XENOTHERA is a clinical stage biotech company developing First-In-Class drugs mainly in oncology and hematology."}]